Where I see patients (2)
My reviews
Selected research
-
Exploration of a Potential DOOR Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Using Six Registrational Trials for Antibacterial Drugs.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
-
The positioning of ceftobiprole in the treatment of Staphylococcus aureus bacteremia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
-
A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2.
Annals of internal medicine
Clinical trials
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
Each participant will be placed in 1 of 5 DOOR levels based on overall clinical response and treatment-related adverse events (AE). The 5 DOOR levels are as follows: successful clinical response and no treatment-related AE (Level ...
Recruiting
5.0